Assessment of copulative function and severity of lower urinary tract symptoms in patients with benign prostatic hyperplasia after transurethral enucleation

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

AIM: was to conduct a comparative assessment of copulative function and the severity of lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH) who underwent laser and bipolar transurethral enucleation of the prostate and who treated conservatively.

MATERIALS AND METHODS: 143 BPH patients aged 50 to 80 years (mean age 65 years) with complaints of copulatory and urinary disorders were under observation. All patients were divided into two groups. The 1st (main) group included 102 patients who underwent surgical treatment: transurethral laser enucleation of the prostate (n = 55) and transurethral bipolar enucleation of the prostate (n = 47). Patients of the 2nd group (n = 41) received conservative treatment. Control examinations were performed before treatment, 4, 12 and 24 weeks after it.

RESULTS: All 102 patients of group 1, regardless of the type of surgery, noted retrograde ejaculation four weeks after surgery. In the majority of patients of the 1st group during these periods weakening of orgasm was noted, in a significant number – deterioration of erection and decreased libido were noted. Upon further observation, by the 12th week after the operation, restoration of all components of the copulatory function was noted, with the exception of ejaculation. By the 24th week of observation, only in 2 patients of the 1st group the normal mechanism of ejaculation was restored. Surgical treatment of patients in group 1, regardless of the method of surgery, led to a significant decrease in the severity of LUTS, an increase in the maximum urine flow rate, a decrease in the volume of the prostate gland and the amount of residual urine. There were no significant differences in the dynamics of these indicators depending on the method of transurethral enucleation. The patients of the 2nd group also had an improvement in clinical parameters, but it was much less pronounced than in the 1st group.

CONCLUSION: Laser and bipolar transurethral enucleation of the prostate are effective surgical techniques that significantly improve the outflow of urine from the bladder, reduce the severity of LUTS and improve the sexual function of patients. Surgery is well tolerated by patients. At the same time, almost all patients operated on by these methods develop retrograde ejaculation.

About the authors

Pavel S. Vydrin

I.I. Mechnikov North-Western State Medical University; Alexandrovskaya Hospital

Author for correspondence.
Email: pavyd@yandex.ru
ORCID iD: 0000-0003-2711-7711
SPIN-code: 9031-2133

Postgraduate Student, Urologist

Russian Federation, 41, Kirochnaya str., Saint Petersburg, 191015; 4, Solidarity Avenue, Saint Petersburg, 193312

Svetlana N. Kalinina

I.I. Mechnikov North-Western State Medical University

Email: kalinina_sn@mail.ru
ORCID iD: 0000-0003-4280-3015
SPIN-code: 3359-2846

Dr. Sci. (Med.), Professor of the Department of Urology

Russian Federation, 41, Kirochnaya str., Saint Petersburg, 191015

Oleg O. Burlaka

I.I. Mechnikov North-Western State Medical University; Alexandrovskaya Hospital

Email: burlaka@list.ru
ORCID iD: 0000-0001-6405-9405
SPIN-code: 4318-5117

Cand. Sci. (Med), Head of the Urological Unit; Assistant Professor of the Department of Urology

Russian Federation, 41, Kirochnaya str., Saint Petersburg, 191015; 4, Solidarity Avenue, Saint Petersburg, 193312

Michail S. Aleksandrov

Alexandrovskaya hospital

Email: kalinina_sn@mail.ru

Urologist

Russian Federation, 4, Solidarity Avenue, Saint Petersburg, 193312

References

  1. Ministerstvo zdravookhraneniya Rossiiskoi Federatsii. Dobrokachestvennaya giperplazii predstatel’noi zhelezy. Klinicheskie rekomendatsii Ministerstva zdravookhraneniya Rossiiskoi Federatsii. Moscow, 2020. (In Russ.) Available from: https: // cr.minzdrav.gov.ru/schema/6_1
  2. Gravas S, Cornu NJ, Gacci M, et al. Management of Non-neurogenic Male LUTS. European Association of Urology Guidelines. Available from: http: // uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/
  3. Pushkar’ DYu, Rasner PI, Kharchilava RR. Lower urinary tract symptoms and benign prostatic hyperplasia. Urologiia. 2016;(2):4–19. (In Russ.) doi: 10.18565/urol.2017.3-supplement.4-18
  4. Tiktinskii OL, Kalinina SN, Mikhailichenko VV. Andrologiya. Moscow: MIA. 2010. 576 p. Moscow: MIA, 2010. 576 p. (In Russ.)
  5. Alyaev YuG, Glybochko PV, Pushkar’ DYu (editors). Urologiya. Rossiiskie klinicheskie rekomendatsii. Moscow: GEOTAR-Media, 2018. 480 p. (In Russ.)
  6. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3): 474–479. doi: 10.1016/s0022-5347(17)49698-4
  7. Al-Shukri SKh, Tkachuk VN, Gorbachev AG, et al. Urodinamicheskie issledovaniya v diagnostike infravezikal’noi obstruktsii u muzhchin. Urologiya i nefrologiya. 1998;(6):27–29. (In Russ.)
  8. Al-Shukri SKh, Kuzmin IV. Quality of life in patients with overactive bladder. Urologicheskie vedomosti. 2011;1(1):21–26. (In Russ.) doi: 10.17816/uroved57653
  9. Taylor BC, Wilt TJ, Fink HA, et al. Osteoporotic Fractures in Men (MrOS) Study Research Group. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology. 2006;68(4):804–809. doi: 10.1016/j.urology.2006.04.019
  10. Korneyev IA, Alexeeva TA, Al-Shukri SKh, Pushkar DYu. Lower urinary tract symptoms in male population of the Russian Federation North-Western region: analysis of population study results. Urologicheskie vedomosti. 2016;6(1):5–9. (In Russ.) doi: 10.17816/uroved615-9
  11. Kupelian V, McVary KT, Kaplan SA, et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey. J Urol. 2013;189(1):107–116. doi: 10.1016/j.juro.2012.11.026
  12. Kalinina SN, Burlaka OO, Aleksandrov MS, Vydryn PS. Diagnosis and treatment of lower urinary tract symptoms and erectile dysfunction in patients with benign prostate hyperplasia. Urologicheskie vedomosti. 2018;8(1):26–33. (In Russ.) doi: 10.17816/uroved8126-33
  13. Kuzmin IV, Ajub AKh, Slesarevskaya MN. Phosphodiesterase type 5 inhibitors in treatment of lower urinary tract dysfunctions. Urology reports (St. Petersburg). 2020;10(1):67–74. (In Russ.) doi: 10.17816/uroved10167-74
  14. Al-Shukri AS, Kostyukov SV. Possibilities of phytotherapy in patients with lower urinary tract symptoms due to benign prostate enlargement. Urology reports (St. Petersburg). 2020;10(4):317–323. (In Russ.) doi: 10.17816/uroved48969
  15. Al-Shukri SKh, Gorbachev AG, Borovets SYu, et al. Prostatilen treatment of prostatic adenoma. Urologiia. 2006;(6):22–25. (In Russ.)
  16. Park T, Choi JY. Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis. World J Urol. 2014;32(4):1093–1105. doi: 10.1007/s00345-014-1258-9
  17. Peshekhonov KS, Shpilenia ES, Burlaka OO. Significance of the pharmacoeconomic approach in the choice of treatment of hyperplasia of the prostate. Urologicheskie vedomosti. 2019;9(4):59–72. (In Russ.) doi: 10.17816/uroved9459-72
  18. Gandhi J, Weissbart SJ, Smith NL, et al. The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia. Transl Androl Urol. 2017;6(2):295–304. doi: 10.21037/tau.2017.03.57
  19. Mustafaev AT, Kyzlasov PS, Dianov MP, et al. Surgical treatment of benign prostatic hyperplasia: the past and the present. Urologicheskie vedomosti. 2019;9(1):47–56. (In Russ.) doi: 10.17816/uroved9147-56
  20. Ahyai SA, Lehrich K, Kuntz RM. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol. 2007;52(5):1456–1463. doi: 10.1016/j.eururo.2007.04.053
  21. Sevryukov FA, Sorokin DA, Karpukhin IV, et al. Transurethral enucleation of prostate (TUEB) – new option in bipolar endoscopic surgery of BPH. Experimental & clinical urology. 2012;(2):34–36. (In Russ.)
  22. Martov AG, Ergakov DV, Turin DE, Andronov AS. Bipolar and laser endoscopic enucleation for large benign prostatic hyperplasia. Urologiia. 2020;(1):59–63. (In Russ.) doi: 10.18565/urology.2020.1.59-63
  23. Robert G, Cornu JN, Fourmarier M, et al. Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP). BJU Int. 2016;117(3):495–499. doi: 10.1111/bju.13124
  24. Gilling PJ, Aho TF, Frampton CM, et al. Holmium laser enucleation of the prostate: results at 6 years. Eur Urol. 2008;53(4):744–749. doi: 10.1016/j.eururo.2007.04.052
  25. Alyaev YuG, Vinarov AZ, Akhvlediani ND. Ehrektil’naya disfunktsiya posle transuretral’nykh operatsii po povodu giperplazii predstatel’noi zhelezy. Vrachebnoe soslovie. 2004;(7):37. (In Russ.)
  26. Efremov EA, Dorofeev SD. Ehrektil’naya disfunktsiya u patsientov, perenesshikh transuretral’nye ehndoskopicheskie operativnye vmeshatel’stva na predstatel’noi zheleze po povodu ee dobrokachestvennoi giperplazii. RMZH. 2004;(8):527. (In Russ.) [Cited 15.06.2021]. Available from: https: // www.rmj.ru/articles/urologiya/Erektilynaya_disfunkciya_u_pacientov_perenesshih_transuretralynye_endoskopicheskie_operativnye_vmeshatelystva_na_predstatelynoy_gheleze_po_povodu_ee_dobrokachestvennoy_giperplazii/
  27. Placer J, Salvador C, Planas J, et al. Effects of holmium laser enucleation of the prostate on sexual function. J Endourol. 2015;29(3):332–339. doi: 10.1089/end.2014.0502
  28. Popov SV, Orlov IN, Grin YA, et al. State of copulative function in patients after the holmium laser enuсleation of benign prostatic hyperplasia. Urologicheskie vedomosti. 2019;9(2):17–22. (In Russ.) doi: 10.17816/uroved9217-22
  29. Kyzlasov PS, Martov AG, Popov SV, et al. Erectile dysfunction after transurethral surgery for benign prostatic hyperplasia. Journal of VolgSMU. 2017;(3):10–15. (In Russ.) doi: 10.19163/1994-9480-2017-3(63)-10-15
  30. Frieben RW, Lin HC, Hinh PP, et al. The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review. Asian J Androl. 2010;12(4):500–508. doi: 10.1038/aja.2010.33
  31. Kim SH, Yang HK, Lee HE, et al. HoLEP does not affect the overall sexual function of BPH patients: a prospective study. Asian J Androl. 2014;16(6):873–877. doi: 10.4103/1008-682X.132469.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies